Mobilization of CD34+ cells in elderly patients (≥ 70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen
Authors:
Open Access
- 6 February 2003
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 120 (3) , 413-423
Abstract
Summary. The mobilization of peripheral blood stem cells was studied in 984 multiple myeloma patients, including 106 patients aged ≥ 70 years. Increasing age correlated inversely with CD34+ yield (P < 0·0001), but also with ≥ 12 months of prior standard chemotherapy (P = 0·0001), < 200 × 109/l platelets (P = 0·0006) premobilization and mobilization with growth factors only (P = 0·0001). After controlling for these age covariates, multivariate analysis identified ≤ 12 months standard therapy and platelet count ≥ 200 × 109/l premobilization as favourable variables (both P < 0·0001), while increasing patient age remained an unfavourable factor (P = 0·0009). With both favourable variables, 85% of elderly patients collected ≥ 4 × 106/kg CD34+ cells in a median of one collection. The effect of age was incremental with no age threshold showing acceleration in the decline of CD34+ yield. Chemotherapy significantly increased CD34+ yield compared with growth factors only. However, the subgroup of patients with > 12 months prior therapy and premobilization platelet count < 200 × 109/l mobilized as many CD34+ cells with granulocyte colony‐stimulating factor (G‐CSF) alone as with chemotherapy and haematopoietic growth factors. Increasing patient age had no effect on post‐transplant neutrophil recovery, but significantly delayed platelet recovery (≥ 50 × 109/l) if < 2 × 106/kg CD34+ cells were infused, but this effect was eliminated completely with infusion of ≥ 4 × 106/kg CD34+ cells. Increasing age adversely affected CD34+ yield even with limited premobilization therapy, indicating that early collection is important in elderly patients.Keywords
This publication has 23 references indexed in Scilit:
- High-dose therapy and innovative approaches to treatment of multiple myelomaSeminars in Hematology, 2001
- Collection de cellules souches périphériques, recherche de facteurs prédictifs: une étude multicentriqueTransfusion Clinique et Biologique, 2000
- Blood stem cell collections in multiple myeloma: definition of a scoring systemBone Marrow Transplantation, 2000
- Factors Influencing Collection and Engraftment of CD34 + Cells in Patients with Breast Cancer Following High-Dose Chemotherapy and Autologous Peripheral Blood Progenitor Cell TransplantationJournal of Hematotherapy & Stem Cell Research, 2000
- Hemopoiesis in healthy old people and centenarians: well-maintainedresponsiveness of CD34+ cells to hemopoietic growth factors and remodelingof cytokine networkThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2000
- Peripheral stem cell mobilization and engraftment in patients over age 60Bone Marrow Transplantation, 1997
- A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple MyelomaNew England Journal of Medicine, 1996
- Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG‐CSF): an analysis of factors correlating with the tempo of engraftment after transplantationBritish Journal of Haematology, 1994
- Increased cytokine production in mononuclear cells of healthy elderly peopleEuropean Journal of Immunology, 1993
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958